Reuters logo
BRIEF-Jiangsu Hengrui Medicine and unit get approval for drug clinical trial
March 10, 2017 / 8:33 AM / 7 months ago

BRIEF-Jiangsu Hengrui Medicine and unit get approval for drug clinical trial

March 9 (Reuters) - Jiangsu Hengrui Medicine Co Ltd :

* Says the co and its unit received approval from China Food and Drug Administration to start new drug SHR-1309 injection clinical trial

* SHR-1309 injection is used for HER2 positive metastatic breast cancer treatment

* The co and its unit will be able to sell SHR-1309 injection after getting approval from China Food and Drug Administration

Source text in Chinese: goo.gl/j8XXer

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below